Trial ChiCTR2000031809
Publication Xia S, JAMA, 2020
Primary outcome on the report: Injection site–specific adverse reactions and systemic adverse reactions within 7 days of each injection and the neutralizing antibody titers and the specific IgG-binding antibody titers

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.